Physician profile
Judy Tan
NPI 1023682093
$3,700.29
in general payments reported to CMS, 2019-2025
14 companies · $2,445 in 2025
The $2,445 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,256 · 2025: $2,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,155 · Travel and Lodging: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,155.11 |
| Travel and Lodging | $545.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,041.31 | 2024-2025 | Stravix, Grafix Pl, Stravix Mesh |
| Eclipse Technology Solutions INC. | $876.44 | 2024-2025 | |
| Stryker Corporation | $476.42 | 2024-2025 | Ortholoc 3di, Citrefix, Variax |
| Paladin Technology Solutions | $287.08 | 2025 | |
| Paratek Pharmaceuticals, INC. | $255.54 | 2024-2025 | Nuzyra |
| Arthrex, INC. | $208.00 | 2025 | |
| Stability Biologics, LLC | $135.00 | 2025 | |
| Depuy Synthes Sales INC. | $132.10 | 2024 | Vivigen Mis Delivery System, Motoband Cp, Dynaforce |
| Averitas Pharma INC. | $82.63 | 2025 | Qutenza |
| Trice Medical, INC. | $72.94 | 2024 | |
| Solventum Corporation | $53.73 | 2025 | Activ.A.C. |
| Treace Medical Concepts, INC. | $35.17 | 2025 | |
| Kerecis Limited | $24.76 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Urgo Medical North America, LLC | $19.17 | 2025 | Urgoclean Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.